"We are MercyOne: a connected system of health care facilities and services dedicated to helping you live your best life."

During the past decade, Mercy Medical Center - North Iowa conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 49 clinical trials were completed, i.e. on average, 350% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 20 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Medical Center - North Iowa" #1 sponsor was "National Cancer Institute (NCI)" with 37 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "Gynecologic Oncology Group" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Medical Center - North Iowa" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "NRG Oncology" with 4 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Medical Center - North Iowa" are "Recurrent Breast Carcinoma" (5 trials), "Breast Adenocarcinoma" (4 trials), "Breast Cancer" (4 trials), "HER2/Neu Negative" (4 trials) and "Stage IIIB Breast Cancer AJCC v7" (4 trials). Many other conditions were trialed in "Mercy Medical Center - North Iowa" in a lesser frequency.

Most popular intervention types in "Mercy Medical Center - North Iowa" are "Drug" (57 trials), "Other" (48 trials), "Biological" (28 trials), "Procedure" (7 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (34 trials), "Quality-of-Life Assessment" (17 trials), "Bevacizumab" (11 trials), "Paclitaxel" (10 trials) and "Carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Medical Center - North Iowa" are 51 trials for "All" genders, 12 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Medical Center - North Iowa". undefined are not yet recruiting, 3 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Mercy Medical Center - North Iowa, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Medical Center - North Iowa, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".